January 4, 2018 / 5:44 PM / 18 days ago

BRIEF-Asterias Biotherapeutics Reports Milestone Targets For 2018

Jan 4 (Reuters) - Asterias Biotherapeutics Inc:

* ASTERIAS BIOTHERAPEUTICS INC - AS OF DECEMBER 31, 2017, ASTERIAS’ CASH AND CASH EQUIVALENTS TOTALED APPROXIMATELY $21.6 MILLION

* ASTERIAS BIOTHERAPEUTICS SAYS INTENDS TO CONTINUE DISCUSSIONS WITH FDA TO ACHIEVE CLEARANCE ON DESIGN OF NEXT STUDY FOR AST-OPC1

* ASTERIAS BIOTHERAPEUTICS SAYS HAS SUFFICIENT RESOURCES TO FUND OPERATIONS THROUGH MID-2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below